These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18240910)

  • 21. Providers' utilization and perceptions of warfarin dosing algorithms.
    Gardner T; Vazquez SR; Kim K; Jones AE; Witt DM
    Thromb Res; 2019 Nov; 183():4-12. PubMed ID: 31505378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision dosing of warfarin: open questions and strategies.
    Li X; Li D; Wu JC; Liu ZQ; Zhou HH; Yin JY
    Pharmacogenomics J; 2019 Jun; 19(3):219-229. PubMed ID: 30745565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing the frequency of attendance at a warfarin dosing clinic.
    Blann AD; Bareford D
    Clin Lab Haematol; 2001 Jun; 23(3):205-7. PubMed ID: 11553065
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacogenomics and warfarin.
    Anderson DC
    Am J Health Syst Pharm; 2009 Jan; 66(2):121. PubMed ID: 19139475
    [No Abstract]   [Full Text] [Related]  

  • 25. Determining the adjusted initial treatment dose of warfarin anticoagulant medicine using kernel-based support vector regression.
    Maghsoudi R; Mirzarezaee M; Sadeghi M; Nadjar-Araabi B
    Comput Methods Programs Biomed; 2022 Feb; 214():106589. PubMed ID: 34963093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic approach to warfarin dosing using a decision-making algorithm.
    Cherpak C
    J Am Acad Nurse Pract; 1994 Oct; 6(10):485-8. PubMed ID: 7848737
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trial evidence of the promise of pharmacogenomics warfarin dosing algorithms.
    Motsinger-Reif AA; Wagner MJ
    Pharmacogenomics; 2012 Jun; 13(8):861-3. PubMed ID: 22676190
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring the distribution of warfarin in blood plasma.
    Rosengren AM; Karlsson BC; Nicholls IA
    ACS Med Chem Lett; 2012 Aug; 3(8):650-2. PubMed ID: 24900525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen.
    Wigle TJ; Jansen LE; Teft WA; Kim RB
    J Pers Med; 2017 Dec; 7(4):. PubMed ID: 29236081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacogenomics of warfarin from the COAG and EU-PACT: where do we go from here?
    Wu AH; Superko HR
    Per Med; 2014 May; 11(3):247-249. PubMed ID: 29764060
    [No Abstract]   [Full Text] [Related]  

  • 31. A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals.
    Barajas MR; Formea CM; McCormick JB; Abdalrhim AD; Han LC; McBane RD; Fiksdal AS; Kullo IJ
    Curr Pharm Teach Learn; 2015; 7(2):249-255. PubMed ID: 25729462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computing optimal drug dosing with OptiDose: implementation in NONMEM.
    Bachmann F; Koch G; Bauer RJ; Steffens B; Szinnai G; Pfister M; Schropp J
    J Pharmacokinet Pharmacodyn; 2023 Jun; 50(3):173-188. PubMed ID: 36707456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically Guided Warfarin Dose Versus Genotyping In Early Achievement Of Stable Anticoagulant Effect Of Warfarin.
    Makar-Ausperger K; Bozina N; Erdeljic Turk V; Likic R; Radacic Aumiler M; Ganoci L; Francetic I
    Clin Ther; 2016 Oct; 38(10S):e10. PubMed ID: 27673603
    [No Abstract]   [Full Text] [Related]  

  • 34. Hematology-led, software-assisted warfarin dosing vs. manual dosing in hemodialysis patients.
    Ward F; Clince M; Hayes M; O'Shea S
    Hemodial Int; 2021 Jan; 25(1):140-141. PubMed ID: 32996220
    [No Abstract]   [Full Text] [Related]  

  • 35. A review of warfarin dosing and monitoring.
    Kuruvilla M; Gurk-Turner C
    Proc (Bayl Univ Med Cent); 2001 Jul; 14(3):305-6. PubMed ID: 16369639
    [No Abstract]   [Full Text] [Related]  

  • 36. Culture bound syndromes: Need to relook, relabel and include?
    Balhara YP; Goyal R
    Asian J Psychiatr; 2011 Mar; 4(1):75. PubMed ID: 23050921
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.
    Shahin MH; Khalifa SI; Gong Y; Hammad LN; Sallam MT; El Shafey M; Ali SS; Mohamed ME; Langaee T; Johnson JA
    Pharmacogenet Genomics; 2011 Mar; 21(3):130-5. PubMed ID: 21228733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing Chinese race-specific warfarin dose prediction algorithms.
    Gao W; Zhang Z; Guan Z; Chen W; Li Z
    Int J Clin Pharm; 2023 Jun; 45(3):731-738. PubMed ID: 36991222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Simple Formula for Predicting the Maintenance Dose of Warfarin with Reference to the Initial Response to Low Dosing at an Outpatient Clinic.
    Shoji M; Suzuki S; Otsuka T; Arita T; Yagi N; Semba H; Kano H; Matsuno S; Kato Y; Uejima T; Oikawa Y; Matsuhama M; Yajima J; Yamashita T
    Intern Med; 2020 Jan; 59(1):29-35. PubMed ID: 31511484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge.
    Alsaloumi L; Abdi A; Tosun Ö; Başgut B
    Int J Clin Pharm; 2019 Oct; 41(5):1299-1306. PubMed ID: 31267362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.